毒素A作为急性获得性并发性食otropia的治疗方式 - 一个印度的视角
Akshay Badakere1, Vibha Badrinath1, Hennaav Kaur Dhillon1
1Department of Pediatric Ophthalmology and Strabismus, Medical Research Foundation, Chennai, Tamil Nadu, India.
Indian journal of ophthalmology
|August 26, 2024
概括
毒素A注射是一种安全有效的治疗急性获得并发性食otropia (AACE). 大多数患者实现了症状的缓解,尽管有些人需要进一步的治疗,如镜或重复注射.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
- 斯特拉比斯摩斯的管理管理
背景情况:
- 急性并发性食热症 (AACE) 是一种具有挑战性的疾病,需要有效的治疗策略.
- 毒素A注射为管理AACE提供了一个潜在的非手术方法.
研究的目的:
- 评估毒素A注射在AACE患者中的疗效和安全性.
- 确定影响AACE治疗结果的因素.
主要方法:
- 在2022年1月至2023年2月期间接受毒素A治疗的AACE患者的回顾性分析.
- 纳入标准:AACE诊断,Botox治疗和至少3个月的随访.
- 进行了全面的眼科,骨科和神经成像评估.
主要成果:
- 在27名患者中,66.6% (18) 患者出现了完全的症状消失.
- 四名患者需要镜,两名患者需要重复注射,每个人都接受了手术或分歧治疗.
- 六名患者患有死;没有显著的风险因素影响了结果.
结论:
- 毒素注射到中间直肠肌肉是AACE的安全和可行的治疗方法.
- 关于潜在的并发症,如死和需要进一步干预的患者咨询至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
413
Angle Closure Glaucoma: Treatment
454
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
454
Accessory Structures of the Eye
1.5K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
1.5K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
707
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
707
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
662
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
662
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K


